InMode Ltd. ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, ...

According to Nova One Advisor, the global immunoassays market size is calculated at USD 28.51 billion in 2025 and is expected ...

The Company is increasing its revenue guidance for the full year 2025, to a range of $2,700 million to $2,750 million and narrowing adjusted EBITDA guidance to a range of $175 million to $195 million.

Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...

TME Pharma advances its new investment strategy and signs LOI with German resources company A further step toward investment diversification into potential cash-flow–generating assets A potential ...

The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, ...